Search

Home > Lung Cancer Considered > FDA Approval: Adjuvant Alectinib for Resected NSCLC
Podcast: Lung Cancer Considered
Episode:

FDA Approval: Adjuvant Alectinib for Resected NSCLC
Category: Science & Medicine
Duration: 00:38:13
Publish Date: 2024-04-18 22:07:43
Description: In the wake of the FDA's approval of alectinib for resected non-small cell lung cancer, Lung Cancer Considered host Dr. Narjust Florez and Dr. Benjamen Solomon discuss this development and take a deeper look at the ALINA trial, which played an important role in the drug's approval.
Total Play: 0